companydata.dkNORDIC BIOTECH PRIVATE INVESTORS ApS: Financial statements 2017
CVR: 26284384
NORDIC BIOTECH PRIVATE INVESTORS ApS (CVR 26284384) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 47,493,597 and a net result of DKK 2,930,034 compared with DKK -24,655,553 the year before. Equity amounted to DKK 13,104,166. The solvency ratio was 99.4%.
- Gross Profit
- 47,493,597 kr.
- Profit/Loss
- 2,930,034 kr.
- Equity
- 13,104,166 kr.
- Total Assets
- 13,189,042 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 47.5 mio. | 2.9 mio. | 13.1 mio. | - |
| 2016 | - | -21 t. | -24.7 mio. | 56.8 mio. | - |
| 2015 | - | -20 t. | 14.9 mio. | 81.4 mio. | - |
| 2014 | - | -16 t. | 39.3 mio. | 66.5 mio. | - |
| 2013 | - | -90 t. | 7.2 mio. | 27.2 mio. | - |
Find more companies like NORDIC BIOTECH PRIVATE INVESTORS ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
NORDIC BIOTECH PRIVATE INVESTORS ApS has published its annual report for 2016. Gross profit came to DKK -21,250, and the net result was DKK -24,655,553.
About NORDIC BIOTECH PRIVATE INVESTORS ApS
NORDIC BIOTECH PRIVATE INVESTORS ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company was registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Mosegaard Larsen. The company's owners include Thue Walter Schwartz, Peter Moldt and Dorte Kloppenborg Skrumsager. In 2025, the company reported a gross profit of DKK -432,293 and a net result of DKK -571,396 compared with DKK 2,080,087 the year before. Equity amounted to DKK 2,975,449.